Expert Outlook: Sarepta Therapeutics Through The Eyes Of 25 Analysts
Expert Outlook: Sarepta Therapeutics Through The Eyes Of 25 Analysts
專家展望：sarepta therapeutics在25位分析師的眼中
Ratings for Sarepta Therapeutics (NASDAQ:SRPT) were provided by 25 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在過去三個月中，25位分析師對Sarepta Therapeutics (NASDAQ:SRPT)的評級提供了看好和看淡的觀點。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他們最近的評級快照，展示了情緒在過去30天中的演變情況，並將其與之前的月份進行比較。
In the assessment of 12-month price targets, analysts unveil insights for Sarepta Therapeutics, presenting an average target of $182.8, a high estimate of $235.00, and a low estimate of $128.00. Marking an increase of 10.38%, the current average surpasses the previous average price target of $165.61.
在對12個月的股價目標進行評估時，分析師們揭示了Sarepta Therapeutics的一些見解，提出了一個平均目標價$182.8，一個高估價$235.00和一個低估價$128.00。目前的平均價比以前的平均價$165.61高了10.38%。
Decoding Analyst Ratings: A Detailed Look
分析師評級解讀：詳細解析
The standing of Sarepta...
通過對最...
登入免費觀看全文
登入/註冊